AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 132 filers reported holding AMICUS THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 0.79 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $7,952,000 | -17.2% | 816,500 | -31.8% | 0.93% | -24.2% |
| Q3 2019 | $9,607,000 | -50.1% | 1,197,900 | -22.3% | 1.23% | -7.8% |
| Q2 2019 | $19,236,000 | -12.0% | 1,541,400 | -4.0% | 1.33% | +31.8% |
| Q1 2019 | $21,847,000 | +191.0% | 1,606,400 | +105.0% | 1.01% | +95.2% |
| Q4 2018 | $7,507,000 | +399.5% | 783,700 | +530.0% | 0.52% | +502.3% |
| Q3 2018 | $1,503,000 | -64.5% | 124,400 | -55.8% | 0.09% | -68.3% |
| Q1 2018 | $4,236,000 | +8.7% | 281,700 | +4.0% | 0.27% | +29.7% |
| Q4 2017 | $3,898,000 | +183.1% | 270,900 | +7.4% | 0.21% | +62.0% |
| Q2 2016 | $1,377,000 | +39.4% | 252,300 | +51.6% | 0.13% | -12.8% |
| Q3 2014 | $988,000 | – | 166,400 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 21,719,191 | $226,748,000 | 8.80% |
| Perceptive Advisors | 27,372,917 | $285,773,000 | 8.29% |
| Palo Alto Investors LP | 9,847,774 | $102,811,000 | 8.13% |
| Finepoint Capital LP | 1,688,400 | $17,627,000 | 5.80% |
| CM Management, LLC | 450,000 | $4,698,000 | 5.24% |
| Avoro Capital Advisors LLC | 26,800,000 | $279,792,000 | 5.17% |
| Artal Group S.A. | 4,000,000 | $41,760,000 | 1.78% |
| Kynam Capital Management, LP | 676,849 | $7,066,000 | 1.49% |
| Ghost Tree Capital, LLC | 500,000 | $5,220,000 | 1.46% |
| Boxer Capital, LLC | 2,325,000 | $24,273,000 | 1.36% |